Equities Research Analysts’ Updated EPS Estimates for January, 5th (AAC, AAPL, AVXS, DBK, EVHC, FFIV, JNPR, LLNW, MCD, NVDA)

Equities Research Analysts’ updated eps estimates for Friday, January 5th:

AAC (NYSE:AAC) had its buy rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $14.00 price target on the stock. The analysts wrote, “Yesterday, AAC announced that it had entered into a settlement term sheet for $25 million related to a previously disclosed securities class action lawsuit. The company also reached an agreement-in-principle for a derivative action.””

Apple (NASDAQ:AAPL) was given a $190.00 target price by analysts at UBS Group AG. The firm currently has a buy rating on the stock.

AveXis (NASDAQ:AVXS) had its buy rating reissued by analysts at Chardan Capital. Chardan Capital currently has a $135.00 target price on the stock. The analysts wrote, “We would encourage buying on any AVXS weakness today, on the potential that the market may have understandably misunderstood what could be an atypical but stepped up process in terms of filing timelines for AVXS-101 in SMA type 1. Our take: Our base case (see our 15 June 2017 note) of a filing after pivotal STR1VE (NCT03306277) phase III data seems to have been improved upon. There are reasons to believe AveXis could file AVXS-101 by 3Q18, with a blue skies” scenario involving AVXS-101 approval by end-2018 or early-2019. We note AveXis’ appropriately non-promotional commentary when executing its duties in communicating status of important regulatory matters to the market.””

Deutsche Bank (FRA:DBK) was given a €17.50 ($20.83) target price by analysts at DZ Bank AG. The firm currently has a buy rating on the stock.

Envision Healthcare (NYSE:EVHC) had its hold rating reissued by analysts at Cantor Fitzgerald. They currently have a $37.00 price target on the stock. The analysts wrote, “Increasing 2018 estimates and updating PT. We are increasing our 2018 adjusted EPS estimate to $3.95 from $3.40 to reflect a lower corporate tax rate that adds $0.57 to adjusted EPS, offset by changes in the timing and estimated net proceeds from the AMR divestiture, which is now expected to close in 1Q18. Our adjusted 2018 EBITDA estimate remains $982 million, but our new price target reflects higher free cash flow from the lower taxes, and incremental margin improvements from reduced overhead labor costs.””

F5 Networks (NASDAQ:FFIV) had its sell rating reiterated by analysts at Deutsche Bank AG.

Juniper Networks (NYSE:JNPR) had its sell rating reissued by analysts at Deutsche Bank AG. Deutsche Bank AG currently has a $20.00 target price on the stock.

Limelight Networks (NASDAQ:LLNW) had its buy rating reiterated by analysts at B. Riley. The firm currently has a $6.00 target price on the stock.

McDonald's (NYSE:MCD) had its buy rating reaffirmed by analysts at Cowen Inc. They currently have a $200.00 target price on the stock.

NVIDIA (NASDAQ:NVDA) had its buy rating reaffirmed by analysts at Goldman Sachs Group Inc. They currently have a $228.00 target price on the stock.

Perrigo (NYSE:PRGO) was given a $107.00 price target by analysts at Cantor Fitzgerald. The firm currently has a buy rating on the stock.

Regenxbio (NASDAQ:RGNX) had its buy rating reissued by analysts at Raymond James Financial, Inc..

Revance Therapeutics (NASDAQ:RVNC) had its buy rating reiterated by analysts at Mizuho. They currently have a $54.00 price target on the stock.

Starbucks (NASDAQ:SBUX) had its buy rating reiterated by analysts at Piper Jaffray Companies. The firm currently has a $70.00 price target on the stock.

Sientra (NASDAQ:SIEN) had its buy rating reissued by analysts at Canaccord Genuity. Canaccord Genuity currently has a $19.00 target price on the stock.

Smith & Nephew (NYSE:SNN) had its buy rating reissued by analysts at Canaccord Genuity. The firm currently has a $45.00 price target on the stock.

Sonic (NASDAQ:SONC) had its price target increased by UBS Group AG from $26.00 to $28.00. The firm currently has a neutral rating on the stock.

Sonic (NASDAQ:SONC) had its hold rating reiterated by analysts at Oppenheimer Holdings Inc..

Viveve Medical (NASDAQ:VIVE) had its buy rating reiterated by analysts at Mizuho. Mizuho currently has a $10.00 price target on the stock.

Wayfair (NYSE:W) had its hold rating reiterated by analysts at Citigroup Inc. Citigroup Inc currently has a $80.00 price target on the stock.

WNS (NYSE:WNS) had its buy rating reaffirmed by analysts at Cantor Fitzgerald. The firm currently has a $42.00 price target on the stock.

Zimmer Biomet (NYSE:ZBH) had its hold rating reissued by analysts at Canaccord Genuity. Canaccord Genuity currently has a $132.00 target price on the stock.

Receive News & Ratings for AAC Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AAC Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply